Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer

Viral mimicry describes the immune response induced by endogenous stimuli such as double-stranded RNA (dsRNA) from endogenous retroelements. Activation of viral mimicry has the potential to kill cancer cells or augment anti-tumor immune responses. Here, we systematically identify mechanisms of viral...

Full description

Bibliographic Details
Main Authors: Hosseini, A, Lindholm, HT, Chen, R, Mehdipour, P, Marhon, SA, Ishak, CA, Moore, PC, Classon, M, Di Gioacchino, A, Greenbaum, B, De Carvalho, DD
Format: Journal article
Language:English
Published: Cell Press 2024
_version_ 1826312107985993728
author Hosseini, A
Lindholm, HT
Chen, R
Mehdipour, P
Marhon, SA
Ishak, CA
Moore, PC
Classon, M
Di Gioacchino, A
Greenbaum, B
De Carvalho, DD
author_facet Hosseini, A
Lindholm, HT
Chen, R
Mehdipour, P
Marhon, SA
Ishak, CA
Moore, PC
Classon, M
Di Gioacchino, A
Greenbaum, B
De Carvalho, DD
author_sort Hosseini, A
collection OXFORD
description Viral mimicry describes the immune response induced by endogenous stimuli such as double-stranded RNA (dsRNA) from endogenous retroelements. Activation of viral mimicry has the potential to kill cancer cells or augment anti-tumor immune responses. Here, we systematically identify mechanisms of viral mimicry adaptation associated with cancer cell dependencies. Among the top hits is the RNA decay protein XRN1 as an essential gene for the survival of a subset of cancer cell lines. XRN1 dependency is mediated by mitochondrial antiviral signaling protein and protein kinase R activation and is associated with higher levels of cytosolic dsRNA, higher levels of a subset of Alus capable of forming dsRNA, and higher interferon-stimulated gene expression, indicating that cells die due to induction of viral mimicry. Furthermore, dsRNA-inducing drugs such as 5-aza-2'-deoxycytidine and palbociclib can generate a synthetic dependency on XRN1 in cells initially resistant to XRN1 knockout. These results indicate that XRN1 is a promising target for future cancer therapeutics.
first_indexed 2024-03-07T08:22:37Z
format Journal article
id oxford-uuid:0e3ca8b6-205d-475b-87b3-1bb5e123d4d8
institution University of Oxford
language English
last_indexed 2024-03-07T08:22:37Z
publishDate 2024
publisher Cell Press
record_format dspace
spelling oxford-uuid:0e3ca8b6-205d-475b-87b3-1bb5e123d4d82024-02-06T15:16:58ZRetroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0e3ca8b6-205d-475b-87b3-1bb5e123d4d8EnglishSymplectic ElementsCell Press2024Hosseini, ALindholm, HTChen, RMehdipour, PMarhon, SAIshak, CAMoore, PCClasson, MDi Gioacchino, AGreenbaum, BDe Carvalho, DDViral mimicry describes the immune response induced by endogenous stimuli such as double-stranded RNA (dsRNA) from endogenous retroelements. Activation of viral mimicry has the potential to kill cancer cells or augment anti-tumor immune responses. Here, we systematically identify mechanisms of viral mimicry adaptation associated with cancer cell dependencies. Among the top hits is the RNA decay protein XRN1 as an essential gene for the survival of a subset of cancer cell lines. XRN1 dependency is mediated by mitochondrial antiviral signaling protein and protein kinase R activation and is associated with higher levels of cytosolic dsRNA, higher levels of a subset of Alus capable of forming dsRNA, and higher interferon-stimulated gene expression, indicating that cells die due to induction of viral mimicry. Furthermore, dsRNA-inducing drugs such as 5-aza-2'-deoxycytidine and palbociclib can generate a synthetic dependency on XRN1 in cells initially resistant to XRN1 knockout. These results indicate that XRN1 is a promising target for future cancer therapeutics.
spellingShingle Hosseini, A
Lindholm, HT
Chen, R
Mehdipour, P
Marhon, SA
Ishak, CA
Moore, PC
Classon, M
Di Gioacchino, A
Greenbaum, B
De Carvalho, DD
Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
title Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
title_full Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
title_fullStr Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
title_full_unstemmed Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
title_short Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
title_sort retroelement decay by the exonuclease xrn1 is a viral mimicry dependency in cancer
work_keys_str_mv AT hosseinia retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT lindholmht retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT chenr retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT mehdipourp retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT marhonsa retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT ishakca retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT moorepc retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT classonm retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT digioacchinoa retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT greenbaumb retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer
AT decarvalhodd retroelementdecaybytheexonucleasexrn1isaviralmimicrydependencyincancer